
SCCMPod-564 CCE: Endotoxin Activity and Precision Medicine in Septic Shock
·38 min·3 clips
Dr. John Kellum discusses a septic shock endotype with 60% mortality, driven by high endotoxin activity.
As heard by us
A careful review of how endotoxin activity may refine prognosis and treatment selection in septic shock.
Endotoxin activity gives this episode its clearest way into septic shock, with Marilyn Bullitt and Dr. John A. Kellum weighing what the EAA test can tell clinicians about prognosis and possible treatment selection.
Why you'd press play
Press play when familiar sepsis markers leave you wanting a clearer read on septic shock risk and who might benefit from targeted treatment.
Listen to the show on